Last reviewed · How we verify

NCT06030791

BTB Graft Harvest and Donor Site Morbidity After ACL Reconstruction

Status unknown Last updated 11 September 2023
What this trial tests

trial testing MRI in Anterior Cruciate Ligament Rupture in 60 participants. Status unknown.

Timeline
31 October 2022
Primary endpoint
31 October 2024
31 October 2024

Quick facts

Lead sponsorClinical Center of Vojvodina
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date31 October 2022
Primary completion31 October 2024
Estimated completion31 October 2024
Sites1 location across Serbia

Drugs / interventions tested

Conditions studied

Sponsor

Clinical Center of Vojvodina

Who can join

Adults 18 to 45, any sex, with Anterior Cruciate Ligament Rupture or Donor Site Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this observational study is to examine the connection between bone-tendinous defects after BTB graft harvest and the development of anterior knee pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

Other recruiting trials for Anterior Cruciate Ligament Rupture

Currently open trials in the same condition.

Other Clinical Center of Vojvodina trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06030791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing